Craft

Olympus

Stock Price

¥2.6 K

2024-06-28

Market Capitalization

¥3 T

2024-06-28

Revenue

¥936.2 B

FY, 2024

Olympus Summary

Company Summary

Overview
Olympus (オリンパス株式会社) is a company that manufactures and sells medical machinery and instruments. It operates through two divisions: endoscopic solutions and therapeutic solutions. The endoscopic sector includes gastrointestinal and surgical endoscopy systems, endoscope reprocessors, digital healthcare solutions, and a repair center. The therapeutic sector provides endotherapy, urology, respiratory devices and systems, rhino-laryngo scopes, etc.
Type
Public
Status
Active
Founded
1919
HQ
Shinjuku City, JP | view all locations
Website
https://www.olympus-global.com
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Stefan Kaufmann

    Stefan Kaufmann, Director, Representative Executive Officer, President and Chief Executive Officer

  • Naoki Okada

    Naoki Okada, Managing Director, Korea

    • Marc Radatt

      Marc Radatt, Chief Executive Officer, APAC

    • Samson Chan

      Samson Chan, Managing Director, Hong Kong

      Operating MetricsView all

      Colonoscopies Performed

      50M

      FY, 2023

      Diseases Treated

      100

      FY, 2023

      Participants Served

      13.8K
      31.4%

      FY, 2023

      LocationsView all

      52 locations detected

      • Shinjuku City, Tokyo HQ

        Japan

        2-chōme-3-1 Nishishinjuku

      • Center Valley, PA

        United States

        3500 Corporate Pkwy

      • Miami, FL

        United States

        5301 Blue Lagoon Drive, Suite 290

      • Westborough, MA

        United States

        800 W Park Dr

      • Victoria, VIC

        Australia

        3 Acacia Place, Notting Hill

      • Vienna, Wien

        Austria

        Shuttleworthstrasse 25

      and 46 others

      Olympus Financials

      Summary Financials

      Revenue (FY, 2024)
      ¥936.2B
      Gross profit (FY, 2024)
      ¥695.7B
      Net income (FY, 2024)
      ¥27.0B
      Cash (FY, 2024)
      ¥340.9B
      EBIT (FY, 2024)
      ¥43.6B
      Enterprise value
      $3.0T

      Footer menu